Immunophenotyping characteristics of COVID-19 patients: Peripheral blood CD8+ HLA-DR+ T cells as a biomarker for mortality outcome.

Autor: Mirsharif ES; Immunoregulation Research Center, Shahed University, Tehran, Iran., Chenary MR; Simorgh Clinical Laboratory, Tehran, Iran., Bozorgmehr M; Simorgh Clinical Laboratory, Tehran, Iran., Mohammadi S; Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran., Hashemi SM; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Ardestani SK; Department of Immunology, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran., Beigmohammadi MT; Department of Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Abdollahi A; Department of Pathology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Sadeghipour A; Medicine Department of Pathology, School of Medicine, Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran., Kariminia A; School of Medicine, University of Washington, Seattle, Washington, USA., Tuserkani F; Immunoregulation Research Center, Shahed University, Tehran, Iran., Ghazanfari T; Immunoregulation Research Center, Shahed University, Tehran, Iran.; Simorgh Clinical Laboratory, Tehran, Iran.

Publikováno v: Journal of medical virology [J Med Virol] 2023 Jan; Vol. 95 (1), pp. e28192. Date of Electronic Publication: 2022 Oct 19.